Comerica Bank’s Achieve Life Sciences ACHV Stock Holding History

Comerica Bank’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$11.8K	Sell	2,382 -31	-1%	-$135	﹤0.01%	3208
2025 Q3	$7.6K	Sell	2,413 -42	-2%	-$115	﹤0.01%	3311
2025 Q2	$5.55K	Sell	2,455 -45	-2%	-$128	﹤0.01%	3349
2025 Q1	$6.67K	Hold	2,500	–	–	﹤0.01%	3270
2024 Q4	$8.8K	Hold	2,500	–	–	﹤0.01%	3198
2024 Q3	$11.8K	Hold	2,500	–	–	﹤0.01%	3148
2024 Q2	$11.8K	Hold	2,500	–	–	﹤0.01%	3125
2024 Q1	$11.4K	Hold	2,500	–	–	﹤0.01%	3161
2023 Q4	$10.3K	Sell	2,500 -3,000	-55%	-$13.1K	﹤0.01%	3144
2023 Q3	$23.6K	Buy	+5,500	New	+$27.7K	﹤0.01%	2952

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's ACHV Position: Q4 2025 in Review

Comerica Bank reduced its Achieve Life Sciences (ACHV) stake by 1.3% in Q4 2025, selling an estimated $135 and leaving 2,382 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

Comerica Bank first reported a position in ACHV in Q3 2023 and has held it in 10 quarters since. The position peaked at $23.6K in Q3 2023. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.

Comerica Bank held 2,382 shares of Achieve Life Sciences worth $11.8K as of Q4 2025.
Comerica Bank sold 31 Achieve Life Sciences shares in Q4 2025, an estimated $135.
Achieve Life Sciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3208 holding.
Comerica Bank first reported a position in Achieve Life Sciences in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Achieve Life Sciences position peaked at $23.6K in Q3 2023.
77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.